Proxim Diagnostics
Sunnyvale, US · Delaware corporation
Proxim develops a handheld point-of-care immunodiagnostic device that runs laboratory-grade blood tests near the patient using whole blood, with a low-cost disposable test cartridge. Its test menu covers women's health, sepsis, cardiology, and infectious disease, targeting hospital emergency departments in the USA and other clinical settings globally.
Founders & leadership
MB
Mikhail BrimanCEO, Co-Founder, Chairman
VJ
Vikram JoshiCo-Founder, Board Director
Board
SB
Sergey BelonozhkoBoard director
TS
Thomas ShannonBoard director
AS
Andy ShragoBoard director
Reported raises · per SEC filings
Form D private placements$22M disclosed across 3 rounds · 2016–2022
▶$18MraisedNov 2022 · 1 investors · Other TechnologyRule 506(b)
▶$18MraisedNov 2022 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas ShannonDirector
- Sergey BelonozhkoDirector
- Mikhail BrimanExecutive Officer, Director
- Offering amount
- $18M
- Amount sold
- $18M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.7MraisedOct 2018 · 8 investors · Other TechnologyRule 506(b)
▶$1.7MraisedOct 2018 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Mikhail BrimanExecutive Officer, Director
- Thomas ShannonDirector
- Sergey BelonozhkoDirector
- Offering amount
- $10.2M
- Amount sold
- $1.7M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.3MraisedMar 2016 · 12 investors · Other Health CareRule 506(b)
▶$2.3MraisedMar 2016 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mikhail BrimanExecutive Officer, Director
- Sergey BelonozhkoDirector
- Thomas ShannonDirector
- Andy ShragoDirector
- Vikram JoshiExecutive Officer
- Offering amount
- $3M
- Amount sold
- $2.3M
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapLabcorp9 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
MDxHealth6 shared keywordsMDxHealth is a commercial-stage precision diagnostics company offering molecular diagnostic tests to guide the diagnosis and treatment of prostate cancer and other urologic diseases. Its tests use proprietary genetic, epigenetic, and molecular technologies and serve physicians, patients, payers, and providers.
Molecular Devices6 shared keywordsMolecular Devices provides automated systems and services to support 3D cell biology research workflows, including cell culture automation, organoid expansion services, and imaging analysis tools for drug discovery and preclinical research.
Companies competing with Proxim Diagnostics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Proxim Diagnostics do?
- Proxim develops a handheld point-of-care immunodiagnostic device that runs laboratory-grade blood tests near the patient using whole blood, with a low-cost disposable test cartridge. Its test menu covers women's health, sepsis, cardiology, and infectious disease, targeting hospital emergency departments in the USA and other clinical settings globally.
- Who founded Proxim Diagnostics?
- Proxim Diagnostics was founded by Mikhail Briman, Vikram Joshi.
- How much funding has Proxim Diagnostics raised?
- Proxim Diagnostics has disclosed $22M raised across 3 rounds.
- Where is Proxim Diagnostics headquartered?
- Proxim Diagnostics is headquartered in Sunnyvale, US.